Weiss Multi Strategy Advisers LLC Glycomimetics Inc Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.6 - $13.12 $106,000 - $131,200	-10,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.96 - $13.44 $49,800 - $67,200	-5,000 Reduced 33.33%	10,000 $125,000
Q4 2018 Feb 14, 2019	SELL	$8.47 - $14.71 $184,662 - $320,707	-21,802 Reduced 59.24%	15,000 $142,000
Q3 2018 Nov 14, 2018	BUY	$13.7 - $17.12 $2,192 - $2,739	160 Added 0.44%	36,802 $530,000
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.19 $49,127 - $64,440	-3,358 Reduced 8.4%	36,642 $591,000
Q1 2018 May 15, 2018	BUY	$16.06 - $25.35 $642,400 - $1.01 Million	40,000 New	40,000 $649,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.